These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 26000843)

  • 1. Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR.
    Boettcher M; McManus MT
    Mol Cell; 2015 May; 58(4):575-85. PubMed ID: 26000843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technology: fast forward.
    Pham JW
    Mol Cell; 2015 May; 58(4):559. PubMed ID: 26000838
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeted Mutagenesis in Zebrafish Using CRISPR RNA-Guided Nucleases.
    Hwang WY; Fu Y; Reyon D; Gonzales AP; Joung JK; Yeh JR
    Methods Mol Biol; 2015; 1311():317-34. PubMed ID: 25981483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi?
    Unniyampurath U; Pilankatta R; Krishnan MN
    Int J Mol Sci; 2016 Feb; 17(3):291. PubMed ID: 26927085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9: how research on a bacterial RNA-guided mechanism opened new perspectives in biotechnology and biomedicine.
    Charpentier E
    EMBO Mol Med; 2015 Apr; 7(4):363-5. PubMed ID: 25796552
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research progress in the third-generation genomic editing technology - CRISPR/Cas9].
    Zhou Y; Zong Y; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):713-6. PubMed ID: 27577230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas: From the Bacterial Adaptive Immune System to a Versatile Tool for Genome Engineering.
    Kirchner M; Schneider S
    Angew Chem Int Ed Engl; 2015 Nov; 54(46):13508-14. PubMed ID: 26382836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic engineering and the future of medicine.
    Doudna JA
    JAMA; 2015 Feb; 313(8):791-2. PubMed ID: 25710652
    [No Abstract]   [Full Text] [Related]  

  • 9. CRISPR: gene editing is just the beginning.
    Ledford H
    Nature; 2016 Mar; 531(7593):156-9. PubMed ID: 26961639
    [No Abstract]   [Full Text] [Related]  

  • 10. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Taylor J; Woodcock S
    J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond silencing--engineering applications of RNA interference and antisense technology for altering cellular phenotype.
    Hebert CG; Valdes JJ; Bentley WE
    Curr Opin Biotechnol; 2008 Oct; 19(5):500-5. PubMed ID: 18760358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The New State of the Art: Cas9 for Gene Activation and Repression.
    La Russa MF; Qi LS
    Mol Cell Biol; 2015 Nov; 35(22):3800-9. PubMed ID: 26370509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome engineering using CRISPR/Cas: getting more versatile and more precise at the same time.
    Puchta H
    Genome Biol; 2016 Mar; 17():51. PubMed ID: 26987411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on gene expression regulation techniques in Drosophila.
    Xu RG; Wang X; Shen D; Sun J; Qiao HH; Wang F; Liu LP; Ni JQ
    J Genet Genomics; 2019 Apr; 46(4):213-220. PubMed ID: 31060819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processes.
    Humphrey SE; Kasinski AL
    J Hematol Oncol; 2015 Apr; 8():31. PubMed ID: 25888285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoactivatable CRISPR-Cas9 for optogenetic genome editing.
    Nihongaki Y; Kawano F; Nakajima T; Sato M
    Nat Biotechnol; 2015 Jul; 33(7):755-60. PubMed ID: 26076431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-editing revolution: My whirlwind year with CRISPR.
    Doudna J
    Nature; 2015 Dec; 528(7583):469-71. PubMed ID: 26701037
    [No Abstract]   [Full Text] [Related]  

  • 18. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
    Jo YI; Suresh B; Kim H; Ramakrishna S
    Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR: Move beyond differences.
    Thompson C
    Nature; 2015 Jun; 522(7557):415. PubMed ID: 26108837
    [No Abstract]   [Full Text] [Related]  

  • 20. Monkey kingdom.
    Cyranoski D
    Nature; 2016 Apr; 532(7599):300-2. PubMed ID: 27111614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.